Cargando…
Autophagy, cell death, and cancer
Autophagy is an evolutionarily conserved intracellular catabolic process that is used by all cells to degrade dysfunctional or unnecessary cytoplasmic components through delivery to the lysosome. Increasing evidence reveals that autophagic dysfunction is associated with human diseases, such as cance...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4905302/ https://www.ncbi.nlm.nih.gov/pubmed/27308466 http://dx.doi.org/10.4161/23723556.2014.985913 |
_version_ | 1782437243479130112 |
---|---|
author | Lin, Lin Baehrecke, Eric H |
author_facet | Lin, Lin Baehrecke, Eric H |
author_sort | Lin, Lin |
collection | PubMed |
description | Autophagy is an evolutionarily conserved intracellular catabolic process that is used by all cells to degrade dysfunctional or unnecessary cytoplasmic components through delivery to the lysosome. Increasing evidence reveals that autophagic dysfunction is associated with human diseases, such as cancer. Paradoxically, although autophagy is well recognized as a cell survival process that promotes tumor development, it can also participate in a caspase-independent form of programmed cell death. Induction of autophagic cell death by some anticancer agents highlights the potential of this process as a cancer treatment modality. Here, we review our current understanding of the molecular mechanism of autophagy and the potential roles of autophagy in cell death, cancer development, and cancer treatment. |
format | Online Article Text |
id | pubmed-4905302 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-49053022016-06-15 Autophagy, cell death, and cancer Lin, Lin Baehrecke, Eric H Mol Cell Oncol Review Autophagy is an evolutionarily conserved intracellular catabolic process that is used by all cells to degrade dysfunctional or unnecessary cytoplasmic components through delivery to the lysosome. Increasing evidence reveals that autophagic dysfunction is associated with human diseases, such as cancer. Paradoxically, although autophagy is well recognized as a cell survival process that promotes tumor development, it can also participate in a caspase-independent form of programmed cell death. Induction of autophagic cell death by some anticancer agents highlights the potential of this process as a cancer treatment modality. Here, we review our current understanding of the molecular mechanism of autophagy and the potential roles of autophagy in cell death, cancer development, and cancer treatment. Taylor & Francis 2015-01-26 /pmc/articles/PMC4905302/ /pubmed/27308466 http://dx.doi.org/10.4161/23723556.2014.985913 Text en © 2015 The Author(s). Published with license by Taylor & Francis Group, LLC http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted. |
spellingShingle | Review Lin, Lin Baehrecke, Eric H Autophagy, cell death, and cancer |
title | Autophagy, cell death, and cancer |
title_full | Autophagy, cell death, and cancer |
title_fullStr | Autophagy, cell death, and cancer |
title_full_unstemmed | Autophagy, cell death, and cancer |
title_short | Autophagy, cell death, and cancer |
title_sort | autophagy, cell death, and cancer |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4905302/ https://www.ncbi.nlm.nih.gov/pubmed/27308466 http://dx.doi.org/10.4161/23723556.2014.985913 |
work_keys_str_mv | AT linlin autophagycelldeathandcancer AT baehreckeerich autophagycelldeathandcancer |